# A Study on the Preference of Risperidone Dosage Forms

> **NCT06657430** · — · RECRUITING · sponsor: **Shanghai Mental Health Center** · enrollment: 1000 (estimated)

## Conditions studied

- Schizophrenia
- Bipolar Affective Disorder
- Autism Spectrum Disorder
- Conduct Disorder
- Mental Retardation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06657430
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-19
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06657430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06657430, "A Study on the Preference of Risperidone Dosage Forms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06657430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*